Level C· Early human research exploring benefitsRetrospective StudyEurope PMC

Augmentation blepharoplasty: a review of 500 consecutive patients

Tonnard PL., Verpaele AM., Zeltzer AA.

Retrospective Study on Skin Aging, published in Aesthet Surg J (2013) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Retrospective Study
Journal
Aesthet Surg J (2013)
Reported sample size
—
Source database
Europe PMC
PMID
23515379
DOI
10.1177/1090820x13478966
Citations
56

Abstract (original English)

Background Volume loss in the upper and lower eyelids and in the malar area is now considered a major component of periorbital aging. As classical resection blepharoplasty does not address this loss, filling procedures are becoming increasingly common. Objectives The authors present their experience with periorbital fat grafting in conjunction with routine blepharoplasty to address periorbital aging. Methods Outcomes were retrospectively reviewed for 500 consecutive patients who underwent blepharoplasty in conjunction with the authors' periorbital augmentation technique from January 2008 to September 2011. The augmentation technique was a fine particle fat (microfat) grafting procedure that involved the use of small-diameter cannulae for transfer of autologous fat to the medial part of the upper eyelid, the orbitomalar groove, and the malar area. Results Clinical evaluation and review of patient photographs revealed favorable, natural-looking, and long-lasting improvement of the treated areas. Shortcomings of classical resection blepharoplasty, such as hollowing of the upper eyelids, incomplete blending of the eyelid-cheek junction, and persistent deflation of the midface, were avoided; the full and crisp aspect of the upper and lower eyelids seen at a younger age was regained; and the technique was not associated with the complications seen in an earlier patient series. No maj

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
EyelidsAdipose TissueHumansTreatment OutcomeRejuvenationCosmetic TechniquesLipectomyBlepharoplastyTransplantation, AutologousRetrospective Studies

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research